Efficacy and safety of lactosaminated human serum albumia-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial
Jp. Zarski et al., Efficacy and safety of lactosaminated human serum albumia-adenine arabinoside monophosphate in chronic hepatitis B patients non-responders to interferon therapy: a randomised clinical trial, J HEPATOL, 34(3), 2001, pp. 486-488